谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

VP1-2022: Pre-specified event driven analysis of Overall Survival (OS) in the OlympiA phase III trial of adjuvant olaparib (OL) in germline BRCA1/2 mutation (gBRCAm) associated breast cancer

A. N. J. Tutt,J. Garber,R. D. Gelber,K-A Phillips,A. Eisen,O. T. Johannsson,P. Rastogi,K. Y. Cui, S-A Im,R. Yerushalmi,A. M. Brufsky,M. Taboada, G. Rossi,G. Yothers, C. Singer,L. E. Fein,N. Loman, D. Cameron,C. Campbell,C. E. Geyer

Annals of Oncology（2022）

引用 29|浏览36
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要